Vise Technologies Inc. Takes $4.27 Million Position in HCA Healthcare, Inc. $HCA

Vise Technologies Inc. acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 11,132 shares of the company’s stock, valued at approximately $4,265,000.

A number of other institutional investors and hedge funds also recently modified their holdings of HCA. Chung Wu Investment Group LLC bought a new position in HCA Healthcare during the 2nd quarter worth approximately $27,000. Ameriflex Group Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $27,000. Saudi Central Bank acquired a new stake in HCA Healthcare during the 1st quarter worth $26,000. Cheviot Value Management LLC acquired a new position in HCA Healthcare in the first quarter valued at about $26,000. Finally, WPG Advisers LLC bought a new position in shares of HCA Healthcare during the 1st quarter valued at about $27,000. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

HCA has been the topic of a number of research reports. Robert W. Baird lifted their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research note on Thursday, August 14th. Wolfe Research lowered shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Raymond James Financial set a $525.00 price target on HCA Healthcare in a report on Monday, October 27th. Cowen reissued a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Finally, UBS Group raised their price target on shares of HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have given a Hold rating to the company. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $473.53.

HCA Healthcare Trading Down 3.6%

NYSE HCA opened at $459.30 on Tuesday. The stock has a 50 day moving average of $428.83 and a 200-day moving average of $393.03. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $478.88. The company has a market cap of $104.81 billion, a PE ratio of 17.75, a PEG ratio of 1.38 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter last year, the company posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Insider Buying and Selling

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.30% of the stock is currently owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.